{"nct_id":"NCT04416984","title":"Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults with Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-01","start_date":"2020-05-21","start_date_type":"ACTUAL","primary_completion_date":"2025-08","primary_completion_date_type":"ESTIMATED","completion_date":"2029-05","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["ALLO"]}